EvidentIQ group to launch new eCOA and eFeasibility offerings combining scientific services with a comprehensive software suite usable on any device

2021-03-15T14:36:00+01:00 March 15th, 2021|Featured, News|

Data science group EvidentIQ with operations in Germany, France and the US, announced today the launch of their next generation eCOA and eFeasibility solutions for CROs and study sponsors. In a rapidly growing market, the EvidentIQ offering stands out as it combines a comprehensive tech stack with proven scientific services to support pharmaceutical companies, CROs and sponsor teams throughout the feasibility and clinical outcome data collection phase of their clinical trials.
Click below to find out more 👇
Access to the press release